IL2 and COVID-19: Based on it, the twelve core targets (STAT3, AKT1, EGFR, HSP9AA1, MAPK3, JUN, IL6, VEGFA, TNF, IL2, RELA, and STAT1) could be the most important targets for RSLDP in the treatment of COVID-19.